Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1 2Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Rectal Neoplasms 2Ovarian Neoplasms 2Fallopian Tube Neoplasms 2Stomach Neoplasms 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma 1Rhabdomyosarcoma 1Resectable Pancreatic Carcinoma 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Pelvic Neoplasms 1Mesothelioma, Malignant 1Liposarcoma, Myxoid 1Liposarcoma 1Glioma 1Gastrointestinal Neoplasms 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Basal Cell 1

Interventions

Magnetic Resonance Spectroscopy 7Temozolomide 6Radiotherapy 6fluciclovine F-18 4Topotecan 4fluorodopa F 18 3Biopsy 3niraparib 2abemaciclib 2Standard of Care 2Specimen Handling 2Pemetrexed 2Ketoconazole 2ulixertinib 1temsirolimus 1ribociclib 1posaconazole 1poly ICLC 1pitavastatin 1pembrolizumab 1orludodstat 1lorlatinib 1larotrectinib 1infigratinib 1fisetin 1fimepinostat 1evolocumab 1clevudine 1X-Rays 1Watchful Waiting 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Glioma × X-Rays × Clear all
NCT05045027 2025-11-14

Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma

Jonsson Comprehensive Cancer Center

Phase EARLY_PHASE1 Active not recruiting
36 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡